Development of samarium [32P] phosphate colloid for radiosynoviorthesis applications: preparation, biological and preliminary clinical studies experience.

[1]  J. Luck,et al.  Advances in Radionuclide Therapeutics in Orthopaedics , 2004, The Journal of the American Academy of Orthopaedic Surgeons.

[2]  M. Fischer,et al.  Radionuclide therapy of inflammatory joint diseases. , 2002, Nuclear medicine communications.

[3]  P. Mikosch,et al.  Clinical outcome of radiosynoviorthesis: a meta-analysis including 2190 treated joints , 2002, Nuclear medicine communications.

[4]  T. Abshire,et al.  Radionuclide Synovectomy for Hemophilic Arthropathy: A Comprehensive Review of Safety and Efficacy and Recommendation for a Standardized Treatment Protocol , 2002, Thrombosis and Haemostasis.

[5]  J. Luck,et al.  Phosphate-32 Colloid Radiosynovectomy in Hemophilia: Outcome of 125 Procedures , 2001, Clinical orthopaedics and related research.

[6]  S. Umamaheswari,et al.  Preparation and evaluation of samarium (III) phosphate [(153)Sm] colloid (SMPC) for possible therapeutic use. , 2000, Nuclear medicine and biology.

[7]  S. Vallabhajosula,et al.  Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  R. A. Holmes,et al.  Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  D. Sullivan,et al.  Observations on the intraperitoneal distribution of chromic phosphate (32P) suspension for intraperitoneal therapy. , 1983, Radiology.

[10]  N. Martini,et al.  Intrapleural instillation of radioactive chromic phosphate in malignant pleural effusion. , 1981, Indian journal of cancer.